A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer

被引：1
|
作者：
Oh, D.
Lee, K.
Lee, K.
Sohn, C.
Zang, D.
Ryoo, H.
Song, H.
Kim, J.
Bang, Y.
机构：
[1] Seoul Natl Univ Hosp, Seoul 110744, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea
[3] Yeungnam Univ, Med Ctr, Taegu, South Korea
[4] Pusan Paik Hosp, Pusan, South Korea
[5] Hallym Univ, Sacred Heart Hosp, Anyang, South Korea
[6] Daegu Catholic Univ Hosp, Taegu, South Korea
[7] Keimyung Univ, Dongsan Med Ctr, Taegu, South Korea
[8] Inha Univ Hosp, Inchon, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.4638
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4638
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial of gemcitabine in combination with oxaliplatin and capecitabine in previously untreated metastatic or recurrent pancreatic cancer
    Sym, Sun Jin
    Hong, Junsik
    Jung, Minkyu
    Koo, Yang Seo
    Park, Yeon Ho
    Kim, Koen Kook
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Shin, Dongbok
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [2] A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research
    Oh, Do-Youn
    Lee, Keun Wook
    Lee, Kyung-Hee
    Sohn, Chang-Hak
    Park, Young Suk
    Zang, Dae Young
    Ryoo, Hun-Mo
    Song, Hong-Suk
    Kim, Jin-Soo
    Kang, Hye-Jin
    Kim, Bong-Seog
    Bang, Yung-Jue
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1164 - 1174
  • [3] A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: Combined analysis with translational research
    Oh, D.
    Lee, K.
    Lee, K.
    Sohn, C.
    Park, Y.
    Zang, D.
    Ryoo, H.
    Bang, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research
    Do-Youn Oh
    Keun Wook Lee
    Kyung-Hee Lee
    Chang-Hak Sohn
    Young Suk Park
    Dae Young Zang
    Hun-Mo Ryoo
    Hong-Suk Song
    Jin-Soo Kim
    Hye-Jin Kang
    Bong-Seog Kim
    Yung-Jue Bang
    [J]. Investigational New Drugs, 2012, 30 : 1164 - 1174
  • [5] A PHASE II TRIAL OF GEMCITABINE IN COMBINATION WITH OXALIPLATIN AND CAPECITABINE IN PREVIOUSLY UNTREATED METASETATIC OR RECURRENT PANCREATIC CANCER
    Sym, S. J.
    Hong, J.
    Jung, M.
    Koo, Y. S.
    Park, Y. H.
    Kim, K. K.
    Park, J.
    Cho, E. K.
    Lee, J. H.
    Shin, D. B.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 152 - 152
  • [6] A phase II trial of gemcitabine in combination with oxaliplatin and capecitabine in previously untreated metasetatic or recurrent pancreatic cancer.
    Sym, Sun Jin
    Hong, Junsik
    Jung, Minkyu
    Koo, Yang Seo
    Park, Yeon Ho
    Kim, Koen Kook
    Park, Jinny
    Cho, Eun Kyung
    Lee, Jae Hoon
    Shin, Dong Bok
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Phase II Trial of Erlotinib and Capecitabine for Patients with Previously Untreated Metastatic Colorectal Cancer
    Kozuch, Peter
    Malamud, Steve
    Wasserman, Carrie
    Homel, Peter
    Mirzoyev, Takhir
    Grossbard, Michael
    [J]. CLINICAL COLORECTAL CANCER, 2009, 8 (01) : 38 - 42
  • [8] A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer.
    Lim, Sung Hee
    Yun, Jina
    Lee, Min-Young
    Kim, Han Jo
    Kim, Kyoung Ha
    Kim, Se Hyung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Hong, Dae Sik
    Choi, Hyun Jong
    Moon, Jong Ho
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [9] Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial
    Lim, Sung Hee
    Yun, Jina
    Lee, Min-Young
    Kim, Han Jo
    Kim, Kyoung Ha
    Kim, Se Hyung
    Lee, Sang-Chul
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Seong Kyu
    Lee, Yun Nah
    Moon, Jong Ho
    [J]. YONSEI MEDICAL JOURNAL, 2021, 62 (08) : 671 - 678
  • [10] A phase II study of erlotinib in combination with capecitabine in previously treated patients with metastatic pancreatic cancer.
    Blaszkowsky, LS
    Kulke, KH
    Ryan, DP
    Clark, JW
    Meyerhardt, J
    Zhu, AX
    Lawrence, C
    Fuchs, CS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 332S - 332S
12345